(AGENPARL) – WASHINGTON mar 18 aprile 2023 Content Files PDFXMLTEXTMetadata download Descriptive Metadata (MODS)Preservation Metadata (PREMIS)All Content and Metadata files,…
Browsing: treatment
(AGENPARL) – lun 17 aprile 2023 On 17 April, the WTO circulated three panel reports in the cases brought by…
(AGENPARL) – TOLEDO (OHIO) lun 17 aprile 2023 Researchers at The University of Toledo are helping communities throughout northwest Ohio that…
(AGENPARL) – NEW HAVEN, CONNECTICUT (USA) sab 15 aprile 2023 A Yale-led clinical trial found that the medicine ritlecitinib appears safe…
(AGENPARL) – WASHINGTON sab 15 aprile 2023 Content Files PDFXMLTEXTMetadata download Descriptive Metadata (MODS)Preservation Metadata (PREMIS)All Content and Metadata files,…
(AGENPARL) – OXFORD ven 14 aprile 2023 Researchers from the University of Oxford have reported findings from a Phase 2 clinical…
(AGENPARL) – NEW HAVEN, CONNECTICUT (USA) ven 14 aprile 2023 A new Yale-led clinical trial found that the JAK inhibitor ritlecitinib…
(AGENPARL) – gio 13 aprile 2023 PRESS RELEASE 2023-177-EN Dublin, 13 April 2023 Neuromod Devices Closes €30 Million Financing to…
(AGENPARL) – LONDON gio 13 aprile 2023 Information on Consultant-led Referral to Treatment waiting times, monitoring length of time from…
(AGENPARL) – MASSACHUSETTS AVE CAMBRIDGE (USA) gio 13 aprile 2023 MIT neuroscientists have found a way to reverse neurodegeneration and other…